Effects of baclofen on reserpine-induced vacuous chewing movements in mice

Show simple item record

dc.contributor.author Castro, JPMV
dc.contributor.author Frussa-Filho, R.
dc.contributor.author Fukushiro, D. F.
dc.contributor.author Silva, R. H.
dc.contributor.author Medrano, W. A.
dc.contributor.author Ribeiro, R. D.
dc.contributor.author Abilio, V. C.
dc.date.accessioned 2016-01-24T12:40:59Z
dc.date.available 2016-01-24T12:40:59Z
dc.date.issued 2006-02-15
dc.identifier http://dx.doi.org/10.1016/j.brainresbull.2005.09.019
dc.identifier.citation Brain Research Bulletin. Oxford: Pergamon-Elsevier B.V., v. 68, n. 6, p. 436-441, 2006.
dc.identifier.issn 0361-9230
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/28749
dc.description.abstract We have described that GABA mimetic drugs present the ability to inhibit the expression of reserpine-induced oral movements. in this respect, oral movements is associated with important neuropathologies. This study investigates the effects of an acute or a repeated treatment of different doses of the GABA(B) agonist baclofen, as well as withdrawal from these treatments, on the development and/or expression of reserpine-induced vacuous chewing movements (VCM). Male mice received two injections of vehicle or of 1 mg/kg reserpine separated by 48h. in the first experiment, 24 h later, animals were acutely treated with vehicle or baclofen (1, 2 or 4 mg/kg). in the second experiment, animals were treated with vehicle or baclofen (1 or 4 mg/kg) for four consecutive days receiving a concomitant injection of 1 mg/kg reserpine (or vehicle) on Days 2 and 4. Twenty-four hours later, animals received vehicle or baclofen. Thirty minutes after the last injection, they were observed for quantification of VCM and open-field general activity. the acute administration of all the doses of baclofen abolished the manifestation of reserpine-induced VCM. Repeated treatment with 1 mg/kg baclofen induced tolerance to the ability of an acute injection of this dose to reduce VCM. Treatment with baclofen (4 mg/kg) did not modify spontaneous VCM. Acute administration of the highest dose induced a decrease in general motor activity and a potentiation of the reserpine-induced decrease in general activity. These results reinforce the involvement of GABAcrgic hypofunction in the expression of oral movements and suggest that a repeated treatment with baclofen induces compensatory changes in GABAergic transmission that can attenuate its acute property to decrease VCM. (c) 2005 Elsevier Inc. All rights reserved. en
dc.format.extent 436-441
dc.language.iso eng
dc.publisher Elsevier B.V.
dc.relation.ispartof Brain Research Bulletin
dc.rights Acesso restrito
dc.subject GABA en
dc.subject Parkinsonism en
dc.subject tardive dyskinesia en
dc.subject baclofen en
dc.subject reserpine en
dc.subject mice en
dc.title Effects of baclofen on reserpine-induced vacuous chewing movements in mice en
dc.type Artigo
dc.rights.license http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.contributor.institution Universidade Federal de São Paulo (UNIFESP)
dc.description.affiliation UNIFESP, Escola Paulista Med, Dept Pharmacol, BR-04023062 São Paulo, Brazil
dc.description.affiliationUnifesp UNIFESP, Escola Paulista Med, Dept Pharmacol, BR-04023062 São Paulo, Brazil
dc.identifier.doi 10.1016/j.brainresbull.2005.09.019
dc.description.source Web of Science
dc.identifier.wos WOS:000235585100007


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record




My Account